MNT spoke with Mir Ali, MD, a board-certified general surgeon, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, to find out more about how semaglutide might be able to help lower a person’s dementia risk.

“This class of medications are in widespread use and currently the most effective weight loss medications available,” Ali, who was not involved in the current study, explained. “Finding all the effects of these medications may expand possible indications for these drugs and possibly increase insurance coverage.”

Hypothesizing on potential mechanisms of prevention, Ali told us:

“To my knowledge the exact cause of Alzheimer’s dementia is unknown; obesity in general causes a chronic inflammatory process through the body and this can contribute to many medical issues. Perhaps the decrease in chronic inflammation may lead to reduction in dementia risk.”

MNT also spoke to Manisha Parulekar, MD, FACP, AGSF, CMD, director of the Division of Geriatrics at Hackensack University Medical Center, and co-director of the Center for Memory Loss and Brain Health at Hackensack University Medical Center in New Jersey, about the current research.

Parulekar, who was similarly not involved in this study, commented that people with 2 diabetes have a significantly increased risk of developing Alzheimer’s disease and other forms of dementia, and this research suggests a shared underlying mechanism or pathway.

“Additionally, GLP-1 receptor agonists (like semaglutide) have shown neuroprotective effects,” Parulekar continued. “Preclinical studies (in animals) have demonstrated that GLP-1 receptor agonists can protect neurons, reduce inflammation in the brain, and improve cognitive function.”

“Semaglutide also improves insulin sensitivity and glucose control, and also promotes weight loss. These improvements in metabolic health could indirectly reduce the risk of dementia. For example, better glucose control can reduce vascular damage, which is a contributing factor to vascular dementia. Weight loss can also improve cardiovascular health, which is linked to brain health.”
— Manisha Parulekar, MD, FACP, AGSF, CMD

“Lastly, other diabetes medications have shown potential cognitive benefits,” she added. “Some studies have suggested that other diabetes medications, such as metformin, may also have some protective effects against cognitive declineTrusted Source.”

Source - Medical News Todays